A5038325431- Pancreatitis Pathology and Treatment
- Folate and B Vitamins Research
- Medical Research and Treatments
- Trace Elements in Health
- Prenatal Screening and Diagnostics
- Blood Pressure and Hypertension Studies
- Circular RNAs in diseases
- Diabetes Treatment and Management
- Cancer-related molecular mechanisms research
- Erythropoietin and Anemia Treatment
- Amino Acid Enzymes and Metabolism
- Sulfur Compounds in Biology
- Cancer Research and Treatments
- Renin-Angiotensin System Studies
- Acute Kidney Injury Research
- Biopolymer Synthesis and Applications
- Metabolism, Diabetes, and Cancer
- Peroxisome Proliferator-Activated Receptors
- Autophagy in Disease and Therapy
- Parathyroid Disorders and Treatments
- Chronic Kidney Disease and Diabetes
- Hormonal Regulation and Hypertension
- Intracerebral and Subarachnoid Hemorrhage Research
- Magnesium in Health and Disease
- Renal and related cancers
Dongguan People’s Hospital
2011-2022
Southern Medical University
2020-2022
Since renal fibrosis always predisposes end-stage disease, elucidation of the molecular mechanisms that underlie progression may substantially improve understanding and treatment for failure. Previous studies have highlighted an important counteraction between transforming growth factor β 1 (TGFβ1) bone morphogenic protein 7 (BMP7) in epithelial-to-mesenchymal transition (EMT) tubular epithelial cells during chronic injury. Macrophages are also believed to play a critical role fibrosis....
Objective: To investigate the pregnancy outcomes after transvaginal or transabdominal fetal reduction for higher‐order multifetal pregnancies with four more fetuses. Methods: This retrospective study included 102 patients ovulation induction. The underwent in Reproductive Medical Center of Peking University Third Hospital from January 2000 to December 2020. Methods and reduction. Pregnancy different methods were assessed, including live birth rate, miscarriage preterm labor low birthweight...
Abstract Background: Chronic kidney disease (CKD)-associated anemia (CKD-anemia) is associated with poor survival, and hemoglobin targets are often not achieved current therapies. Phase 3 trials have demonstrated the treatment efficacy of roxadustat for CKD-anemia. This phase four study aims to evaluate long-term (52-week) safety effectiveness in a broad real-world patient population CKD-anemia without dialysis China. Methods: 4 multicenter, open-label, prospective study, conducted from 24...
Phosphorus reduction can prevent against vascular calcification (VC) in chronic kidney disease (CKD), but the mechanisms underlying its actions remain unclear. The aim of present study was to determine effect a fortified phosphorus‑lowing treatment on VC CKD. Serum levels creatinine, blood urea nitrogen (BUN), fibroblast growth factor 23 (FGF23), calcium and phosphorus, plasma parathyroid hormone (PTH) were determined an animal model CKD treated with or without lanthanum. Haematoxylin eosin...
Renal ischemia-reperfusion (I/R) injury is characterized by elevated expression of homocysteine and decreased production hydrogen sulfide (H2S). Cystathionine γ-lyase (CSE) a key factor in the onset renal I/R injury, while IFC-305 can regulate CSE via epigenetic modification. Animal cellular models were established this work, followed H&E staining to evaluate extent tissue under distinct conditions. Several methods, including ELISA, qPCR Western blot, used analyze levels creatinine, H2S...
The following articles have been retracted at the request of Editors and Publisher. After conducting a thorough investigation, SAGE found that submitting authors number papers published in Journal Renin-Angiotensin Aldosterone System ( JRAAS) (listed below) had supplied fabricated contact details for their nominated reviewers. accepted these based on reports by individuals using fake reviewer email accounts. concluding peer review process was therefore seriously compromised, journal decided...
Objective To compare different blood purification techniques on cardiovascular stability in patients with chronic renal failure (CRF) and its inherent possible mechanism. Methods 90patients CRF were randomly divided into 3 groups. Group A (HD Group) was applied times per week hemodialysis (HD) treatment; B (HDF group) 2 a routine standard (HD)treatment 1 time hemodiafiltration (HDF) C (HP dialysis treatment hemoperfusion (HP) combined treatment. The every group is 10 weeks, after that there...